Lidings experts have authored the The Pharma Legal Handbook: Russia — practical directory focused on the key aspects of legislative regulation of pharmaceutical industry in Russia.
Published in association with PharmaBoardroom, a premier online resource for C-Level executives, consultants, regulators and vendors working in Healthcare Life Sciences globally, it answers essential questions about the legal and regulatory environment for pharmaceuticals in Russia.
The Handbook covers major issues linked to regulation, pricing, clinical and preclinical trials, marketing, manufacturing, trademarks and patents in Russia and is a must-have for any company operating in the country or looking to enter the market.
The publication was prepared by Lidings’ Managing Partner, Head of the Pharmaceuticals and Healthcare industry practice Andrey Zelenin, Partner Boris Malakhov and associates Polina Vodogreeva and Maria Vasilieva.
Lidings is a leading legal advisor in Russia, acting as an expert in the statutory regulation of the pharmaceutical industry. The firm’s clients are recognized leaders of the pharmaceutical market, such as AstraZeneca, Boehringer Ingelheim, Merck, Ipsen Pharmaceuticals, Astellas Pharma, Mallinckrodt Pharmaceuticals, MEDA Pharmaceuticals, Sanofi and many others. The firm frequently initiates and supports major international conferences devoted to issues most essential for the pharmaceutical industry in Russia and abroad. Lidings’ experts act as speakers and moderators in discussions on legal support of pharmaceutical companies doing business in the Russian Federation.
The Pharma Legal Handbook: Russia was first published by PharmaBoardroom in October 2018.Chapter 1 Regulatory, Pricing, and Reimbursement Overview pdf, 1.52 Mb